A new Galleri blood test detected 75% of cancers without current screening options, with over half found in early stage I or ...

Guardant Health stock has had several attempts at breaking out of a cup base. The company has a blood test to detect colon cancer.

Among nearly 25 million privately insured adults, significant shifts in colorectal cancer (CRC) screening practices were identified after the onset of COVID-19. 1 Between 2017 and 2024, colonoscopy ...

Exact Sciences is facing backlash for sending unsolicited Cologuard colon cancer screening kits to consumers, sparking ...

Guardant Health is breaking barriers and hoping to get more people screened through the “Shield” test. In 2024, over 53,000 ...

Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your colon cancer ...

Among privately insured individuals, the use of colonoscopy and fecal immunochemical tests decreased after the COVID-19 ...

Insurers should stop mailing colorectal cancer screening kits without the involvement of the patients’ physicians. Doctors ...

Thousands in KY go unscreened for colon cancer because they lack access or don't want colonoscopies or stool-based tests, but ...

After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...

Please provide your email address to receive an email when new articles are posted on . A blood-based test demonstrated high sensitivity for colorectal cancer among individuals with average risk. The ...